Year: 2026
Type: article
Abstract: INTRODUCTION: Individuals with preclinical Alzheimer's disease may develop objective subtle cognitive decline (OSCD) as they transition between the cognitively unimpaired and mild cognitive impairment stages. Selection of individuals with OSCD into clinical trials may provide enrichment for participants likely to benefit from treatment. We examined how choice of operational criteria for OSCD impacted clinical staging. METHODS: We analyzed data from 6154 older adults in the Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease clinical trial to evaluate differences in clinical categorization rates by operational approach, as well as interactions with sex, race, and ethnicity. RESULTS: Multinomial generalized estimating equation models yielded significant differences in clinical categorization rates: Interview-based methods led to the lowest proportion of individuals categorized with OSCD, cognitive screeners yielded the highest proportion, and multi-test neuropsychological methods provided a balance. These main effects were moderated by significant interactions with sex and race/ethnicity. DISCUSSION: Choice of OSCD criteria will have significant impacts on trial sample makeup.
DOI: 10.1002/dad2.70527
Institutions: University of Kentucky, University of Georgia
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,540
OpenAlex ID: W7225654629
